Janssens U - Search Results

1

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.

Greinacher A, Völpel H, Janssens U, Hach-Wunderle V, Kemkes-Matthes B, Eichler P, Mueller-Velten HG, Pötzsch B. Greinacher A, et al. Among authors: janssens u. Circulation. 1999 Jan 5-12;99(1):73-80. doi: 10.1161/01.cir.99.1.73. Circulation. 1999. PMID: 9884382 Clinical Trial.

2

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

Greinacher A, Janssens U, Berg G, Böck M, Kwasny H, Kemkes-Matthes B, Eichler P, Völpel H, Pötzsch B, Luz M. Greinacher A, et al. Among authors: janssens u. Circulation. 1999 Aug 10;100(6):587-93. doi: 10.1161/01.cir.100.6.587. Circulation. 1999. PMID: 10441094 Clinical Trial.

3

Successful thrombolysis of right atrial and ventricle thrombi encircling a temporary pacemaker lead in a patient with heparin-induced thrombocytopenia type II.

Janssens U, Breithardt OA, Greinacher A. Janssens U, et al. Pacing Clin Electrophysiol. 1999 Apr;22(4 Pt 1):678-81. doi: 10.1111/j.1540-8159.1999.tb00514.x. Pacing Clin Electrophysiol. 1999. PMID: 10234725

4

Severe arterial and venous thrombosis in a patient with heparin-induced thrombocytopenia type II.

Janssens U, Klues HG, Greinacher A, Hanrath P. Janssens U, et al. Intensive Care Med. 1997 May;23(5):595-6. Intensive Care Med. 1997. PMID: 9201537 No abstract available.

5

Pathomorphological aspects of heparin-induced thrombocytopenia II (HIT-II syndrome).

Hermanns B, Janssens U, Handt S, Füzesi L. Hermanns B, et al. Among authors: janssens u. Virchows Arch. 1998 Jun;432(6):541-6. doi: 10.1007/s004280050203. Virchows Arch. 1998. PMID: 9672196

6

Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of angiography] in patients with acute myocardial infarction.

Lepper W, Hoffmann R, Kamp O, Franke A, de Cock CC, Kühl HP, Sieswerda GT, Dahl Jv, Janssens U, Voci P, Visser CA, Hanrath P. Lepper W, et al. Among authors: janssens u. Circulation. 2000 May 23;101(20):2368-74. doi: 10.1161/01.cir.101.20.2368. Circulation. 2000. PMID: 10821812 Clinical Trial.

7

Thrombosis of a mitral valve prosthesis in a patient with heparin-induced thrombocytopenia type II.

Vazquez-Jimenez JF, Janssens U, Sellhaus B, Hermanns B, Huegel W, Hanrath P, Messmer BJ. Vazquez-Jimenez JF, et al. Among authors: janssens u. J Thorac Cardiovasc Surg. 1999 Oct;118(4):751-3. doi: 10.1016/S0022-5223(99)70025-5. J Thorac Cardiovasc Surg. 1999. PMID: 10504646 Free article. No abstract available.

8

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis.

Merx MW, Liehn EA, Janssens U, Lütticken R, Schrader J, Hanrath P, Weber C. Merx MW, et al. Among authors: janssens u. Circulation. 2004 Jun 1;109(21):2560-5. doi: 10.1161/01.CIR.0000129774.09737.5B. Epub 2004 May 3. Circulation. 2004. PMID: 15123521

9

[Anticoagulation after venous thrombosis caused by type-II HIT syndrome].

Janssens U. Janssens U. Dtsch Med Wochenschr. 1998 Apr 3;123(14):438-9. Dtsch Med Wochenschr. 1998. PMID: 9581173 German. No abstract available.

10

Electrocardiographic changes in unintentional hypothermia--the J wave.

Janssens U, Schneider B, Hanrath P. Janssens U, et al. Intensive Care Med. 1998 Oct;24(10):1118-9. doi: 10.1007/s001340050729. Intensive Care Med. 1998. PMID: 9840253 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page